Cellect Biotech Stock Rises 71% After Announcing Successful Stem Cell Transplant Procedure – Fox Business
Investopedia |
Cellect Biotech Stock Rises 71% After Announcing Successful Stem Cell Transplant Procedure
Fox Business Cellect Biotechnology Ltd. ADR shares rose 71.3% in heavy volume after the company said on Monday that it had completed the first stem cell transplant procedure in an early/mid-stage clinical trial. The Israel-based biotech said the transplant had been … Cellect Succeeds In First Stem Cell Transplant (APOP) Cellect Biotech Up 65% After Stem Cell Transplant Completed In Phase I/II Trial Cellect Announces Successful First Cancer Patient Stem Cell Transplant |
